PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB)

Historical Holders from Q1 2014 to Q3 2025

Symbol
PACB on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
303M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
186M
Holdings value
$238M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
202
Number of buys
82
Number of sells
-84
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARK Investment Management LLC 10.3% $39.6M 30.9M ARK Investment Management LLC 30 Sep 2025
BlackRock, Inc. 7.7% $25.4M 22.9M BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 5.46% $18.1M 16.3M The Vanguard Group 31 Mar 2025
EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) 4.5% $16.6M 13.4M EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) 30 Jun 2025
MADRONE CAPITAL PARTNERS, LLC 2.8% -57.1% $10.8M -$15.1M 8.48M -58.2% Gregory Boyd Penner 30 Sep 2025
MILLENNIUM MANAGEMENT LLC 0.7% -88.3% $2.45M -$15.8M 2.2M -86.6% Millennium Management LLC 31 Mar 2025

Institutional Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 186M $238M -$15.5M $1.28 202
2025 Q2 198M $246M -$33.4M $1.24 201
2025 Q1 225M $265M -$42.6M $1.18 215
2024 Q4 259M $474M +$51.3M $1.83 224
2024 Q3 232M $394M -$15.1M $1.70 221
2024 Q2 242M $332M -$126M $1.37 221
2024 Q1 265M $992M -$194M $3.75 259
2023 Q4 281M $2.75B +$174M $9.81 264
2023 Q3 263M $2.2B +$60.1M $8.35 269
2023 Q2 254M $3.37B +$3.63M $13.30 261
2023 Q1 253M $2.93B +$337M $11.58 246
2022 Q4 225M $1.84B -$8.47M $8.18 224
2022 Q3 212M $1.23B -$114M $5.81 205
2022 Q2 225M $1.03B -$73.9M $4.42 210
2022 Q1 223M $2.03B +$56.8M $9.10 235
2021 Q4 205M $4.2B +$312M $20.46 242
2021 Q3 189M $4.83B +$390M $25.55 238
2021 Q2 172M $6.03B +$294M $34.97 253
2021 Q1 164M $5.47B -$280M $33.31 249
2020 Q4 140M $3.63B +$744M $25.94 149
2020 Q3 149M $1.47B +$445M $9.87 171
2020 Q2 109M $375M -$26.4M $3.45 145
2020 Q1 117M $359M -$19.5M $3.06 125
2019 Q4 115M $592M -$30M $5.14 133
2019 Q3 118M $607M -$16.6M $5.16 144
2019 Q2 120M $729M -$6.85M $6.05 145
2019 Q1 121M $872M +$96.4M $7.23 157
2018 Q4 107M $793M +$59.4M $7.40 150
2018 Q3 109M $590M +$86.1M $5.41 117
2018 Q2 93.2M $331M +$3.09M $3.55 97
2018 Q1 93.9M $192M +$32.5M $2.05 97
2017 Q4 77.7M $205M -$13.7M $2.64 103
2017 Q3 82M $430M +$22.2M $5.25 95
2017 Q2 79M $281M +$51.6M $3.56 103
2017 Q1 63.5M $328M +$48.9M $5.17 103
2016 Q4 63.2M $240M -$68M $3.80 111
2016 Q3 65M $583M +$26.7M $8.96 127
2016 Q2 61.3M $431M +$17M $7.04 140
2016 Q1 57.9M $491M +$38.9M $8.50 130
2015 Q4 52.3M $687M +$150M $13.13 119
2015 Q3 42.7M $156M -$4.37M $3.66 89
2015 Q2 42.7M $246M +$18.7M $5.76 100
2015 Q1 39.1M $228M +$4.61M $5.84 93
2014 Q4 43.6M $342M +$20.2M $7.84 99
2014 Q3 36.2M $178M -$6.56M $4.91 88
2014 Q2 37.3M $230M -$7.23M $6.18 86
2014 Q1 38.5M $206M +$5.92M $5.35 85